InsiderTrades.com logo

DXRX Insider Trading

Insider Ownership Percentage: 26.32%
Insider Buying (Last 12 Months): £899.97
Insider Selling (Last 12 Months): GBX 0

Diaceutics Insider Trading History Chart

This chart shows the insider buying and selling history at Diaceutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Diaceutics Share Price & Price History

Current Price: GBX 165
Price Change: +0.30 (1.20%)
As of 05/22/2026 12:07 PM ET

This chart shows the closing price history over time for DXRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Diaceutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/30/2026Nick RobertsInsiderBuy90GBX 167£150.30
3/2/2026Jordan ClarkInsiderBuy100GBX 150£150
3/2/2026Nick RobertsInsiderBuy100GBX 150£150
12/23/2025Jordan ClarkInsiderBuy117GBX 128£149.76
12/23/2025Nick RobertsInsiderBuy117GBX 128£149.76
10/1/2025Nick RobertsInsiderBuy91GBX 165£150.15
5/13/2025Peter KeelingInsiderSell500,000GBX 126£630,000
4/28/2025Nick RobertsInsiderBuy126GBX 119£149.94
1/30/2025Graham PatersonInsiderBuy11,643GBX 138£16,067.34
1/28/2025Jordan ClarkInsiderBuy104GBX 144£149.76
9/30/2024Nick RobertsInsiderBuy112GBX 134£150.08
8/28/2024Nick RobertsInsiderBuy113GBX 134£151.42
6/28/2024Nick RobertsInsiderBuy122GBX 1GBX 122
5/22/2024Graham PatersonInsiderBuy39,934GBX 129£51,514.86
3/28/2024Peter KeelingInsiderSell750,000GBX 102£765,000
3/6/2024Graham PatersonInsiderBuy33,564GBX 99£33,228.36
1/30/2024Nick RobertsInsiderBuy152GBX 1GBX 152
10/27/2023Nick RobertsInsiderBuy170GBX 88£149.60
8/29/2023Nick RobertsInsiderBuy139GBX 1GBX 139
6/5/2023Nick RobertsInsiderBuy21,742GBX 92£20,002.64
5/30/2023Nick RobertsInsiderBuy183GBX 82£150.06
See Full Table

SEC Filings (Institutional Ownership Changes) for Diaceutics (LON:DXRX)

32.72% of Diaceutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Diaceutics logo
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.
Read More on Diaceutics

Today's Range

Now: GBX 165
Low: 165
High: 168

50 Day Range

MA: GBX 161.20
Low: 141
High: 180

52 Week Range

Now: GBX 165
Low: 112.25
High: 180

Volume

25,196 shs

Average Volume

152,444 shs

Market Capitalization

£139.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of Diaceutics?

Diaceutics' top insider investors include:
  1. Deborah Davis (Insider)
  2. Graham Paterson (Insider)
  3. Jordan Clark (Insider)
  4. Nick Roberts (Insider)
  5. Peter Keeling (Insider)
  6. Philip Henry Hugh White (Insider)
Learn More about top insider investors at Diaceutics.